baber/WOPTO huggingface dataset:
Patent AU-2019284014-A1 (AU)
Title: Antimicrobial washable pillow
Inventor: RUSSELL SARAH
IPC: A47G9/10
Filed: 2019-12-20
Abstract: A washable pillow comprising of a molded foam core with antimicrobial resistance encased in a 
washable netting and a sleeve. The pillow may be washed and dried using conventional 
household methods without significant damage or loss mechanical properties.
1/3 
10 
36 
14a 
12 44 
14b 
FIG.1I
Patent AU-2019331101-A1 (AU)
Title: A gerbilling-proof monowheel vehicle
Inventor: CAHAN AMOS
IPC: B62K11/00
Filed: 2019-08-26
Abstract: A gerbilling-proof monowheel vehicle comprises: (a) a wheel felloe with a tire thereon; (b) a frame rotatably mounted within the wheel felloe; the frame carrying a passenger seat; (c) moving means configured for propelling the gerbilling-proof monowheel vehicle; and (d) braking means configured for decelerating the gerbilling-proof monowheel vehicle. The gerbilling-proof monowheel further comprises at least two auxiliary wheels side-mounted on the frame for vertically stabilizing the passenger seat and preventing the gerbilling-proof monowheel from side tipover and maintaining said passenger seat in a horizontal position within said wheel felloe.
Patent AU-2019332961-A1 (AU)
Title: Multiple charged ionic compounds derived from polyamines and compositions thereof and methods of preparation thereof
Inventor: DHAWAN ASHISH
IPC: B01D17/04
Filed: 2019-08-28
Abstract: Disclosed herein are the multiple charged cationic or anionic compounds, methods of making thereof, and articles or compositions comprising thereof. The disclosed multiple charged cationic or anionic compounds are derived from polyamines through two reactions: an aza-Michael addition with an activated olefin having an ionic group and a ring-opening reaction with an epoxide. The activated olefin has one of the following formulas (1), (2), or (3), the epoxide is (4), X is NH or O.
Patent AU-2019335373-A1 (AU)
Title: PAPD5 inhibitors and methods of use thereof
Inventor: AGARWAL SUNEET
IPC: A61K31/4375
Filed: 2019-09-05
Abstract: The disclosure relates to compounds that are, e.g., PAP Associated Domain Containing 5 (PAPD5) inhibitors and methods of use thereof.
Patent AU-2019363904-A1 (AU)
Title: Combination of a goggle and a face mask
Inventor: WU ZIQIAN
IPC: A61F9/06
Filed: 2019-09-30
Abstract: An apparatus (100, 1000), comprising: a goggle (200), including a goggle frame (201) and a protective lens (202) installed in the goggle frame (201); a face mask (300) releasably connected to the goggle (200); a detachable pivot-connection structure provided between two lateral sides of the goggle frame (201) and the face mask (300), the detachable pivot-connection structure comprising a pivoting axis substantially parallel to a lateral direction of the goggle frame (201); and a detachable locking structure provided between the goggle frame (210) and the face mask (300), the detachable pivot-connection structure configured to cooperate with the detachable pivot-connection structure to selectively lock the goggle frame (210) and the face mask (300) together.
Patent AU-2019373263-A1 (AU)
Title: System for recognition of biological alteration in human tissues
Inventor: CANEPA STEFANO NICOLÒ
IPC: A61B5/00
Filed: 2019-04-30
Abstract: The present invention is directed to a system for recognition of biological alteration in human tissues using electromagnetic waves in the microwave range, the device comprising: a transmitter device (100) comprising at least one transmitting antenna (101), a transmitter (102), and a power supply (103); a receiving device (200) comprising at least one receiving antenna (201), a receiver (202), a pre-processing module (204), and a power supply (203); a microprocessor (301; 104) and a display (302; 105); wherein the transmitter device (100) and the receiving device (200) are configured to operate at a frequency comprised between 2.0 GHz and 3.0 GHz. In a preferred embodiment, the operating frequency is comprised between 2.3 GHz and 2.5 GHz, and the device is suitable for the detection of a cancer in the human body, for example for the screening of prostate cancer, colorectal cancer, breast cancer, thyroid cancer. The device according to the invention is capable of high sensitivity and accuracy of results and can detect not only the presence, but also the position of a cancer.
Patent AU-2019391700-A1 (AU)
Title: Formulation for use in treating osteoarthritis
Inventor: KUMAGAI YOSHINARI
IPC: A61B17/56
Filed: 2019-09-27
Abstract: A formulation for use in treating osteoarthritis by modifying the shape change of bone(s) underlying articular cartilage is disclosed. The use comprises evaluating the bone shape of the patient's joint, injecting the patient with a peptide of SEQ ID No. 1 or applying other therapeutic interventions that can reduce the shape change of the bone(s) underlying articular cartilage, and thereafter evaluating the bone shape of the patient's joint.
Patent AU-2019396997-A1 (AU)
Title: Vacuum adiabatic body and refrigerator
Inventor: KIM DAEWOONG
IPC: F25D23/02
Filed: 2019-12-09
Abstract: A vacuum adiabatic body according to the present invention includes a first plate member, a second plate member, a sealing part which seals between the first plate member and the second plate member, a conductive resistance sheet which connects the first plate member and the second plate member to each other so as to reduce a heat transfer amount between the first plate member and the second plate member, and at least one reinforcing frame which is installed on at least one of the first plate member and the second plate member to reinforce strength, in which the reinforcement frame includes at least one of at least one of a pair of front frames extending at left and right end portions of the opening in a vertical direction, and at least one of a pair of upper and lower frames of a machine chamber extending in the third space in the vertical direction.
Patent WO-2020248009-A1 (WO)
Title: Improved bra
Inventor: AMMUNDSEN CAROLINE
IPC: A41C3/00
Filed: 2020-01-06
Abstract: A bra having an adjustable back strap that can be altered in length while maintaining the fit of the bra cups to accommodate variations in breast size and under bust or back measurements using a combination of different back strap portions, sliders and wings.
Patent AU-2020203191-A1 (AU)
Title: Combination therapies with psma ligand conjugates
Inventor: OLSON WILLIAM C
IPC: C07K16/30
Filed: 2020-05-15
Abstract: I:\Interwoven\NRPortbl\DCC\FMT\20210425 L.DOCX-15/05/2020 Compositions and methods related to inhibiting the proliferation of or killing of prostate specific membrane antigen (PSMA)-expressing cells are provided herein. In some embodiments, PSMA-expressing cells are contacted with (i) a compound that increases cell surface expression of PSMA and (ii) a PSMA ligand conjugate. In other embodiments, the PSMA-expressing cells are contacted with (i) prednisone and (ii) a PSMA ligand conjugate. In some of these embodiment ts, the PSMA-expressing cells are further contacted with (iii) a compound that increases cell surface expression of PSMA.
Patent AU-2020206487-A1 (AU)
Title: Atmospheric water generator
Inventor: DULBERG SHARON
IPC: E03B3/00
Filed: 2020-01-08
Abstract: The invention discloses an AWG having improvements designed to reduce noise, improve uniform airflow through the evaporator of the AWG and reduce energy consumption. In one embodiment the AWG includes an air inlet located in one of the sidewalls of the enclosure and a blower located in proximity to the air outlet at the bottom wall of the enclosure.
Patent AU-2020214343-A1 (AU)
Title: Reactor systems
Inventor: RUDOLPH ERIC
IPC: C12M1/02
Filed: 2020-01-31
Abstract: This disclosure relates to reaction container systems providing for headspace-based condensation, coalescing devices, and other features. In some embodiments, this disclosure provides systems that reduce the relative humidity (RH) of an exhaust gas prior to or concurrent with its explusion from the system through an exhaust filter.
Patent AU-2020228621-A1 (AU)
Title: Torque limiting connector
Inventor: LEUNG GILBERT
IPC: A61M39/10
Filed: 2020-02-26
Abstract: Torque limiting connectors are described herein. A torque limiting connector includes an outer connector, and inner connector, and a clutch. The outer connector includes a profile disposed on an inner surface of the outer connector. The inner connector may be disposed within the outer connector and can include an upper threaded portion and a lower threaded portion. The clutch can be disposed around and rotationally coupled to the inner connector and can include a plurality of clutch teeth extending from an outer surface of the clutch, wherein the plurality of clutch teeth are outwardly biased to be releasably engaged with the profile of the outer connector. The plurality of clutch teeth can be configured to transfer torque from the outer connector to the inner connector when the torque is below a torque limit, and prevent transfer of torque when the torque exceeds the torque limit.
Patent AU-2020233909-A1 (AU)
Title: Validating and estimating runtime for quantum algorithms
Inventor: JAVADIABHARI ALI
IPC: G06N10/00
Filed: 2020-02-28
Abstract: A method for validation and runtime estimation of a quantum algorithm includes receiving a quantum algorithm and simulating the quantum algorithm, the quantum algorithm forming a set of quantum gates. The method further includes analyzing a first set of parameters of the set of quantum gates and analyzing a second set of parameters of a set of qubits performing the set of quantum gates. The method further includes transforming, in response to determining at least one of the first set of parameters or the second set of parameters meets an acceptability criterion, the quantum algorithm into a second set of quantum gates.
Patent AU-2020242332-A1 (AU)
Title: Process for the depolymerization of polyethylene terephthalate (PET)
Inventor: ESSADDAM ADEL
IPC: C07C27/02
Filed: 2020-03-18
Abstract: The present disclosure relates to the formation of dimethyl terephthalate (DMT) and mono ethylene glycol (MEG). The present invention also relates to the depolymerization of polyethylene terephthalate (PET) and the recovery of dimethyl terephthalate (DMT) and mono ethylene glycol (MEG) using sodium methoxide as a catalyst.
Patent AU-2020243554-A1 (AU)
Title: Ophthalmic laser surgical method and system for forming corneal lenticule with side tab for easy extraction
Inventor: GARCIA JOSE L
IPC: A61B18/20
Filed: 2020-03-12
Abstract: In an ophthalmic laser procedure, a lenticule is formed in the cornea and extracted from the cornea to accomplish vision correction. The ophthalmic laser system is used to form top and bottom lenticule incisions which intersect each other to form an isolated volume of corneal tissue in between. The volume of tissue includes a lenticular portion having a circular or oval shape and a side tab that protrudes from the peripheral of the lenticular portion. The side tab has a radial dimension between 0.5 and 5 mm and a width between 0.5 and 3 mm in. An entry cut is further formed from the anterior corneal surface to the top or bottom lenticule incisions to provide access to the lenticule. During extraction, the surgeon uses the surgical tool to grab the side tab to extract the lenticule.
Patent AU-2020244602-A1 (AU)
Title: Data processing device and data processing method
Inventor: TAKAHASHI KAZUYUKI
IPC: H04H60/25
Filed: 2020-10-02
Abstract: The present technology relates to a data processing 
apparatus and a data processing method capable of 
achieving higher convenience in a case where a plurality 
5 of transmission formats is available in a transmission 
frame.  
The data processing apparatus installed in a 
transmission-side facility processes a transmission frame 
transmitted as a broadcast signal and adds identification 
10 information for identifying the transmission format of 
the transmission frame, while a data processing apparatus 
installed in a reception-side facility processes a 
transmission frame in which a transmission frame has been 
identified, on the basis of identification information 
15 added to the transmission frame transmitted as the 
broadcast signal. The present technology can be applied 
as a method of a test stream, for example.  
16636236_1 (GHMatters) P110117.AU.1
Patent AU-2020245898-A1 (AU)
Title: Method and device for measuring the fibrinogen concentration in blood samples.
Inventor: MANOLIOS JIM
IPC: C12Q1/56
Filed: 2020-03-27
Abstract: A diagnostic device which enables measurement of fibrinogen concentration in a blood sample. The device comprises; a wettable testing substrate including viewing indicators which allow determination of a status of a test. The substrate has a first end and second end and intermediate therebetween a flow receiving zone, a flow path zone and a reaction zone; the reaction zone pre charged with at least one reagent. A blood sample to be tested is deposited near or in either of said flow receiving zone or said reaction zone, the sample reacting with the reagents inducing clotting of the sample. Water added to a dye added to said reaction zone, advances a distance along said substrate. The distance travelled along the substrate by the dye and through the sample is indicative of a measure of concentration of fibrinogen in said blood sample under test.
Patent AU-2020254215-A1 (AU)
Title: CD3 binding molecules
Inventor: VAN LOO PIETER FOKKO
IPC: C07K16/28
Filed: 2020-03-27
Abstract: The invention relates to heavy chain variable regions, binding domains and antibodies specific for human CD3, and CD3 binding proteins. The invention further relates to the use of a CD3 binding protein, preferably an antibody, of the invention in the treatment of cancer or autoimmune disease.
Patent AU-2020274150-A1 (AU)
Title: Cells, tissues, organs, and/or animals having one or more modified genes for enhanced xenograft survival and/or tolerance
Inventor: YANG LUHAN
IPC: A61L27/38
Filed: 2020-05-15
Abstract: Provided are cells, tissues, organs, and/or animals having one or more modified genes for enhanced xenograft survival and/or tolerance. And methods of producing and using the cells, tissues, organs, and/or animals.
Patent AU-2020275488-A1 (AU)
Title: Space-efficient order fulfillment system for workflow between service areas
Inventor: GRAVELLE SCOTT
IPC: B60P1/38
Filed: 2020-05-08
Abstract: An order fulfillment system including an automated storage and retrieval system (ASRS) structure, robotic vehicles, storage bins, and different service areas in a continuous arrangement positioned adjacent to an outer perimeter of the ASRS structure at one or more service levels of the ASRS structure, is provided. The robotic vehicles are navigable within the ASRS structure at the service level(s) positioned above and/or below storage levels of the ASRS structure. The robotic vehicles carry the storage bins within the ASRS structure during transfer of the storage bins to and from storage locations of the ASRS structure. Each service area includes one or more workstations of a type configured for one or more tasks different from one or more workstations at another service area. Each service area receives a drop-off of the storage bins at and/or a travel of the storage bins through each service area by the robotic vehicles.
Patent AU-2020315775-A1 (AU)
Title: Composition and methods of targeting the pre-B cell receptor for the treatment of leukemias and lymphomas
Inventor: GRAY PATRICK
IPC: A61K39/395
Filed: 2020-07-17
Abstract: The present invention relates to antibodies that bind the pre-B cell receptor components VpreB and lambda-5, and compositions comprising such antibodies for use in diagnosing and eliminating pre-BCR-expressing leukemia and lymphoma cells. In one aspect, the present invention provides isolated antibodies or an antigen-binding fragment thereof capable of specifically binding to a SLC. The SLC is composed of two noncovalently-linked polypeptides, VpreB and lambda-5.
Patent AU-2020321466-A1 (AU)
Title: Ophthalmic compositions comprising viscosifying polymers and nucleic acids
Inventor: PLATENBURG GERARDUS JOHANNES
IPC: A61K38/00
Filed: 2020-07-24
Abstract: The invention relates to ophthalmic compositions comprising: i) a nucleic acid molecule, preferably an antisense oligonucleotide, such as an single-stranded antisense oligonucleotide that modulates splice modulation or prevention of RNA toxicity due to trinucleotide repeats in a target RNA molecule, or a gapmer that induces breakdown of a target RNA molecule after formation of a double-stranded RNA/gapmer complex; and ii) a viscosifying polymer. The ophthalmic compositions are for topical administration in the eye of a mammalian subject suffering from a corneal disease, such as a hereditary corneal dystrophy. The viscosifying polymer in the compositions of the invention allows the entry of the nucleic acid molecule to the different layers of the cornea: the corneal epithelium, Bowman's membrane, stroma, Dua's layer, the Descemet's membrane and/or the corneal endothelium.
Patent AU-2020325631-A1 (AU)
Title: Cooking device
Inventor: KLEIN GERHARD
IPC: H05B6/64
Filed: 2020-07-30
Abstract: A cooking device with at least one cooking region comprises a control unit (2) configured to be coupled with a communication interface (12,16) for receiving voice signals as control commands from a user or data signals as control commands from a remote control device. The control unit (2) is configured for controlling a power supply to the at least one cooking region (4-1,4-2,4-3). The control unit (2) is configured to accept commands from the communication interface (12,16) only upon recognition of the presence of the user.
Patent AU-2020334064-A1 (AU)
Title: T-cell immunotherapy specific for WT-1
Inventor: SCHMITT THOMAS M
IPC: A61P35/00
Filed: 2020-08-19
Abstract: The present disclosure provides binding proteins specific for human Wilms tumor protein 1 (WT-1) epitopes, as well as host cells that express the binding proteins. Also provided are polynucleotides that encode a binding protein and vectors that comprise a polynucleotide. Related methods and uses of the presently disclosed compositions are provided for treating diseases or disorders associated with WT-1 expression, such as various cancers.
Patent AU-2020334937-A1 (AU)
Title: Anti-seismic assembly and modular building
Inventor: YE WEIQIANG
IPC: E04H9/02
Filed: 2020-08-21
Abstract: The present application provides an anti-seismic assembly and a modular building. The anti-seismic assembly is provided between a main frame and a movable frame spaced apart from the main frame. The anti-seismic assembly comprises a fixed member and a movable member. The fixed member is provided on a lower surface of the top portion of the main frame. The movable member is used to connect the fixed member to the movable frame. The bottom portion of the movable member is inserted into the top of a column of the movable frame. The movable member is movable in a height direction of the main frame relative to the movable frame. The top of the movable member is connected to the fixed member. The movable member is movable in a horizontal direction relative to the fixed member. In the anti-seismic assembly according to the present application, the movable member is movable in the height direction of the main frame relative to the movable frame, and the movable member is movable in the horizontal direction relative to the fixed member, thereby preventing collision or compression between the movable frame and the main frame.
Patent AU-2020348973-A1 (AU)
Title: Recombinant oncolytic Newcastle Disease Viruses with increased activity
Inventor: THALLER ARNO
IPC: C12N7/00
Filed: 2020-09-02
Abstract: The invention relates to transgene expressing Newcastle Disease Viruses (NDV), which have been demonstrated to possess significant oncolytic activity against mammalian cancers and/or an improved safety profile. The invention provides novel oncolytic viruses through the use of genetic engineering, including the transfer of foreign genes or parts thereof, such as genes encoding Atezolizumab or Bevacizumab. The present invention also provides nucleic acids encoding a reverse genetically engineered (rg-)NDV comprising one or more of these foreign genes and having a mutation in the HN gene, said mutation allowing replication of said rgNDV in a cancer cell to a higher level than replication of an otherwise identical rgNDV not having said mutation in the HN gene.
Patent AU-2020369984-A1 (AU)
Title: Ransomware prevention
Inventor: HOLLAND MATTHEW
IPC: G06F16/17
Filed: 2020-10-20
Abstract: Ransomware attacks may be prevented by monitoring file access requests. When a process requests a directory listing, the results provided may be modified based on whether the process is trusted or not. For trusted processes, the results provided are the actual directory listing, while the results provided to processes that aren't trusted may be modified to include seeded files. Access to the seeded files may be monitored to determine if the process is associated with a ransomware attack, and steps taken to mitigate an attempted ransomware attack. Ransomware may also be prevented by ensuring that only trusted processed are allowed to access certain files. In order to provide an improved user experience, the processes can be determined automatically from a system structure and their trustworthiness determined.
Patent AU-2020379753-A1 (AU)
Title: Controlled production of aqueous halogen solutions with varying compositions
Inventor: BOAL ANDREW
IPC: A01N59/00
Filed: 2020-11-04
Abstract: Methods and systems for the controlled production of aqueous halogen solutions with varying compositions are disclosed. According to an embodiment, aqueous solutions of hypochlorite ions are modified through the sequential addition of pH adjusting chemicals, non-chloride halide ions, and halogen stabilizing compounds. Sensors, for measuring physical and chemical properties of the solutions as they change due to the impact of the various chemical reactions, are linked to a control system which, in turn, can control the input of one or more chemicals. The control system facilitates the production of a solution with desired characteristics in terms of pH, specific halogen composition, degree of halogen stabilization, and limiting the production of undesired byproducts such as bromate ions.
Patent AU-2020396190-A1 (AU)
Title: Use of masitinib for the treatment of eosinophilic asthma
Inventor: MOUSSY ALAIN
IPC: A61P11/06
Filed: 2020-12-02
Abstract: The present invention relates to a 2-aminoarylthiazole derivative or a pharmaceutically acceptable salt or solvate thereof, in particular masitinib or a pharmaceutically acceptable salt or solvate thereof, for use in the treatment of asthma in a subject in need thereof, wherein the subject has an elevated level of eosinophils. In particular, the present invention relates to a 2-aminoarylthiazole derivative or a pharmaceutically acceptable salt or solvate thereof, in particular masitinib or a pharmaceutically acceptable salt or solvate thereof, for use in the treatment of asthma in a subject with an eosinophil blood count at baseline ranging from 150 cells/µL to 300 cells/µL.
Patent AU-2020402701-A1 (AU)
Title: KRas G12C inhibitors
Inventor: BOULET SERGE LOUIS
IPC: C07D498/04
Filed: 2020-12-04
Abstract: The present invention provides compounds of the formula: where R
Patent AU-2020419161-A1 (AU)
Title: Foam-based manufacturing system and process
Inventor: SWAILS MARVIN E
IPC: D21H23/78
Filed: 2020-12-30
Abstract: A system comprising a pulper configured to (i) accept surfactant, a liquid and fiber stock and (ii) generate a foam that suspends the fiber stock, wherein the foam has a half-life; a headbox configured to receive the foam-suspended fiber stock from the pulper and displace the foam-suspended fiber stock onto a forming wire, wherein a time it takes the foam-suspended fiber stock to move from the pulper to the headbox is less than the half-life; and a foam return device that removes at least some of the foam from the forming wire and returns the at least some of the foam to the pulper.